ELV Elevance Health
8-K Current Report
Filed: February 26, 2026
Financials
Hospital & Medical Service PlansElevance Health (ELV) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items2 items
- Item 5.02: Departure/Election of Directors or Officers
- Item 7.01: Regulation FD Disclosure
AI Filing Analysis8-K
Item 5.02 · Departure/Election of Directors or Officers
- • Peter Haytaian exits EVP/President of Carelon role effective May 4, 2026, citing family commitments — not a dispute-driven departure
- • Transitions to Special Advisor through Dec 31, 2026, providing ~8-month runway for leadership transition at Carelon
Item 7.01 · Regulation FD Disclosure
- • Reg FD disclosure: forward-looking statement boilerplate only — no financial data, guidance, or material new information disclosed
- • Key risk factors flagged: healthcare cost trends, Medicare/Medicaid compliance, CMS Star Ratings, cyber threats, and AI system failures
Other Elevance Health 8-K Filings
Get deeper insights on Elevance Health
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.